These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6544124)

  • 1. Phase-I study of protracted infusion of cisplatin.
    Lokich JJ; Zipoli TE
    Cancer Drug Deliv; 1984; 1(3):247-50. PubMed ID: 6544124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system.
    Lokich J; Bothe A; Zipoli T; Green R; Sonneborn H; Paul S; Philips D
    J Clin Oncol; 1983 Jan; 1(1):24-8. PubMed ID: 6668481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase-I study of continuous infusion cyclophosphamide for protracted durations: a preliminary report.
    Lokich JJ; Bothe A
    Cancer Drug Deliv; 1984; 1(4):329-32. PubMed ID: 6544128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
    Pentheroudakis G; Briasoulis E; Karavassilis V; Mauri D; Tzamakou E; Rammou D; Pavlidis N
    Chemotherapy; 2005 May; 51(2-3):154-61. PubMed ID: 15886476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil and methotrexate administered simultaneously as a continuous infusion. A phase I study.
    Lokich JJ; Phillips D; Green R; Paul S; Sonneborn H; Zipoli TE; Curt G
    Cancer; 1985 Nov; 56(10):2395-8. PubMed ID: 4042072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin C: phase I study of a constant infusion ambulatory treatment schedule.
    Lokich J; Perri J; Fine N; Bothe A; Nelson T; Greene R; Zipoli T
    Am J Clin Oncol; 1982 Aug; 5(4):443-7. PubMed ID: 7113965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study.
    Lilenbaum RC; Miller AA; Batist G; Bernard S; Hollis DR; Rosner GL; Egorin MJ; Schilsky RL; Ratain MJ
    J Clin Oncol; 1998 Oct; 16(10):3302-9. PubMed ID: 9779705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
    Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusion.
    Lokich JJ
    Cancer Treat Rep; 1980; 64(8-9):905-8. PubMed ID: 6256073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
    Britten CD; Rowinsky EK; Baker SD; Agarwala SS; Eckardt JR; Barrington R; Diab SG; Hammond LA; Johnson T; Villalona-Calero M; Fraass U; Statkevich P; Von Hoff DD; Eckhardt SG
    Clin Cancer Res; 1999 Jul; 5(7):1629-37. PubMed ID: 10430061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of high-dose cytarabine and cisplatin in patients with advanced malignancy.
    Atkins JN; Muss HB; Capizzi RL; Cooper MR; Craig J; Cruz JM; Jackson DV; Powell B; Richards F; Spurr CL
    Cancer Treat Rep; 1985; 69(7-8):897-9. PubMed ID: 4040427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of protracted venous infusion of 5-fluorouracil.
    Lokich J; Bothe A; Fine N; Perri J
    Cancer; 1981 Dec; 48(12):2565-8. PubMed ID: 7306915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion.
    Salem P; Hall SW; Benjamin RS; Murphy WK; Wharton JT; Bodey GP
    Cancer Treat Rep; 1978 Oct; 62(10):1553-5. PubMed ID: 361227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of continuous infusion cisplatin.
    Posner MR; Ferrari L; Belliveau JF; Cummings FJ; Wiemann MC; O'Rourke A; Weitberg AB; Calabresi P
    Cancer; 1987 Jan; 59(1):15-8. PubMed ID: 3791142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I and pharmacology study of continuous-infusion low-dose methotrexate administration.
    Lokich JJ; Curt G
    Cancer; 1985 Nov; 56(10):2391-4. PubMed ID: 4042071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of spirogermanium given daily.
    Legha SS; Ajani JA; Bodey GP
    J Clin Oncol; 1983 May; 1(5):331-6. PubMed ID: 6668504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ViVACCy--a drug schedule based on G2 blockade and prolonged infusion of multiple tubulin-binding agents. A pilot study.
    Shackney SE; Pugh RP; Zidar BL; Raju RN; Simon SR; Mazur RN; Mucenski JW
    Cancer; 1990 Aug; 66(3):411-7. PubMed ID: 2194639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.
    Egorin MJ; Sigman LM; Van Echo DA; Forrest A; Whitacre MY; Aisner J
    Cancer Res; 1987 Jan; 47(2):617-23. PubMed ID: 3791246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.